This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Doris, P. A. Articles by Stocco, D. M. Search for Related Content PubMed PubMed Citation Articles by Doris, P. A. Articles by Stocco, D. M.

Hypertension, Vol 23, 632-638, Copyright © 1994 by American Heart Association

ARTICLES

Is ouabain an authentic endogenous mammalian substance derived from the adrenal?

PA Doris, LA Jenkins and DM Stocco
Department of Cell Biology and Anatomy, Texas Tech University Health Sciences Center, Lubbock 79430.

Ouabain has recently been reported to be an endogenous mammalian substance released by the adrenal cortex and present in normal plasma. We have attempted to confirm and extend this observation. Using a ouabain radioimmunoassay developed in this laboratory, we fractionated by high-performance liquid chromatography (HPLC) normal human plasma from healthy volunteers to determine the presence of ouabain immunoreactivity and compare this immunoreactivity with authentic ouabain. In most subjects no ouabain immunoreactivity that coeluted with authentic ouabain was observed. Some subjects had ouabain- immunoreactive material present at low levels, but it was largely attributable to cross-reactivity with diverse substances found not to be ouabain. Similar results were obtained after analysis of plasma collected from 10 patients entering a medical intensive care unit. Studies of serum-free medium conditioned by bovine adrenocortical cells showed some ouabain immunoreactivity. To determine whether this material might be a steroid product of cholesterol side-chain cleavage, we performed chemical blockade of steroidogenesis, which effectively suppressed progesterone production by these cells but had no consistent effect on ouabain immunoreactivity in this medium. Stimulation of steroidogenesis with 22-R-OH-cholesterol in bovine adrenocortical cells did not produce any increase in the ouabain immunoreactivity present in conditioned medium. Subsequent HPLC studies of ouabain immunoreactivity in bovine adrenocortical cell-conditioned medium indicated that authentic ouabain did not account for most of the ouabain immunoreactivity in serum-free medium. Studies with bovine adrenocortical cells incubated in a minimal salt and glucose medium indicated a small peak of immunoreactivity that may correspond to authentic ouabain.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. Y. Bagrov, J. I. Shapiro, and O. V. Fedorova Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets Pharmacol. Rev., March 1, 2009; 61(1): 9 - 38. [Abstract] [Full Text] [PDF]

				S. Balzan, D. Neglia, S. Ghione, G. D'Urso, M. C. Baldacchino, U. Montali, and A. L'Abbate Increased circulating levels of ouabain-like factor in patients with asymptomatic left ventricular dysfunction Eur J Heart Fail, March 1, 2001; 3(2): 165 - 171. [Abstract] [Full Text] [PDF]

				O. Vakkuri, S. S. Arnason, P. Joensuu, J. Jalonen, O. Vuolteenaho, and J. Leppaluoto Radioiodinated Tyrosyl-Ouabain and Measurement of a Circulating Ouabain-like Compound Clin. Chem., January 1, 2001; 47(1): 95 - 101. [Abstract] [Full Text] [PDF]

				H. M. A. M. Qazzaz, M. A. El-Masri, and R. Valdes Jr. Secretion of a Lactone-Hydrogenated Ouabain-Like Effector of Sodium, Potassium-Adenosine Triphosphatase Activity by Adrenal Cells Endocrinology, September 1, 2000; 141(9): 3200 - 3209. [Abstract] [Full Text] [PDF]

				R. I. Dmitrieva, A. Y. Bagrov, E. Lalli, P. Sassone-Corsi, D. M. Stocco, and P. A. Doris Mammalian Bufadienolide Is Synthesized From Cholesterol in the Adrenal Cortex by a Pathway That Is Independent of Cholesterol Side-Chain Cleavage Hypertension, September 1, 2000; 36(3): 442 - 448. [Abstract] [Full Text] [PDF]

				A. Kawamura, J. Guo, Y. Itagaki, C. Bell, Y. Wang, G. T. Haupert Jr., S. Magil, R. T. Gallagher, N. Berova, and K. Nakanishi On the structure of endogenous ouabain PNAS, June 8, 1999; 96(12): 6654 - 6659. [Abstract] [Full Text] [PDF]

				C. S. Ho, A. Butt, Y. K. Semra, and R. Swaminathan Effect of Carbidopa on the Excretion of Sodium, Dopamine, and Ouabain-Like Substance in the Rat Hypertension, December 1, 1997; 30(6): 1544 - 1548. [Abstract] [Full Text]

				M. Ferrandi, P. Manunta, S. Balzan, J. M. Hamlyn, G. Bianchi, and P. Ferrari Ouabain-like Factor Quantification in Mammalian Tissues and Plasma : Comparison of Two Independent Assays Hypertension, October 1, 1997; 30(4): 886 - 896. [Abstract] [Full Text]

				S. Harwood, J. A. Little, G. Gallacher, D. Perrett, R. Edwards, and A. Dawnay Development of enzyme immunoassay for endogenous ouabain-like compound in human plasma Clin. Chem., May 1, 1997; 43(5): 715 - 722. [Abstract] [Full Text] [PDF]

				A. Goto, K. Yamada, H. Hazama, Y. Uehara, K. Atarashi, Y. Hirata, K. Kimura, and M. Omata Ouabainlike Compound in Hypertension Associated With Ectopic Corticotropin Syndrome Hypertension, September 1, 1996; 28(3): 421 - 425. [Abstract] [Full Text]

				A. Goto, K. Yamada, H. Nagoshi, Y. Terano, and M. Omata Stress-Induced Elevation of Ouabainlike Compound in Rat Plasma and Adrenal Hypertension, December 1, 1995; 26(6): 1173 - 1176. [Abstract] [Full Text]

				F. H. H. Leenen, B. S. Huang, H. Yu, and B. Yuan Brain `Ouabain' Mediates Sympathetic Hyperactivity in Congestive Heart Failure Circ. Res., November 1, 1995; 77(5): 993 - 1000. [Abstract] [Full Text]

				A. Y. Bagrov, O. V. Fedorova, J. L. Austin-Lane, R. I. Dmitrieva, and D. E. Anderson Endogenous Marinobufagenin-like Immunoreactive Factor and Na+,K+ ATPase Inhibition During Voluntary Hypoventilation Hypertension, November 1, 1995; 26(5): 781 - 788. [Abstract] [Full Text]